Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.
about
Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical TrialsPrognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data.What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy.Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics.Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study.Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapyImpact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging SystemypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer
P2860
Q26796253-D6A89CF1-1A7F-43EB-A243-24636C1DAE96Q36054506-17213304-C081-4448-BA71-983A64C6CCB1Q36314356-E16F9739-EA25-49B8-B801-A8825DCD3E5FQ37097565-C79DA818-EF53-4AEB-B1D7-2E340E645D40Q37204825-70197124-3746-43F9-AFA7-184752C50322Q37328335-41CB010A-C438-4844-A1E7-951807E1AADAQ37672227-80870953-BAC8-4DFC-A32E-C9241EDF366BQ37729169-5658FCBF-E644-4304-AA53-F3DE2C99B29CQ38670280-E0E35794-4C2A-4487-83F9-C1B61D913D52Q39583210-9592FB16-2933-4967-806C-BB951C98AA72Q40870315-6D13B190-EDCF-49F0-BC86-7B5926D017EAQ47580220-8B7CA428-45AB-4B88-A16A-D84F7E169D57Q47947401-093999DC-9433-4E38-B2B6-E32F4225A4A1Q48255590-58565807-C83A-4256-AEF7-2FC1C9AFADB8Q48325554-4183F7DB-BE06-407D-9C13-C797C6E91EF6Q48335407-3299DD69-0618-497F-970D-D843E5B36229Q49503527-F2DE5424-DBF5-4C63-B57E-88D3D3C36408Q49846263-FA3217D4-255F-482E-8CBA-8305D3E60361Q52642667-605AB44B-4029-4E5E-873D-AF7C03544692Q52669254-5929815B-5481-4D67-9CCD-EDC6298E6749Q52873281-A825E75B-388C-4C37-8230-E2FEC756F4EBQ57809077-A212A044-0390-4549-ACB3-C026034CABFDQ58758435-7A0BB502-FE0D-4D5C-BE52-B372631B9290Q59125979-D53687D5-9758-437A-B15D-F90542EA68BF
P2860
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of tumor regression ...... after multimodality treatment.
@ast
Comparison of tumor regression ...... after multimodality treatment.
@en
Comparison of tumor regression ...... after multimodality treatment.
@nl
type
label
Comparison of tumor regression ...... after multimodality treatment.
@ast
Comparison of tumor regression ...... after multimodality treatment.
@en
Comparison of tumor regression ...... after multimodality treatment.
@nl
prefLabel
Comparison of tumor regression ...... after multimodality treatment.
@ast
Comparison of tumor regression ...... after multimodality treatment.
@en
Comparison of tumor regression ...... after multimodality treatment.
@nl
P2093
P2860
P356
P1476
Comparison of tumor regression ...... after multimodality treatment.
@en
P2093
Abraham Wu
Atthaphorn Trakarnsanga
Garrett M Nash
Jinru Shia
José G Guillem
Julio Garcia-Aguilar
Karyn A Goodman
Larissa K Temple
Leonard Saltz
Marc Gollub
P2860
P356
10.1093/JNCI/DJU248
P407
P50
P577
2014-09-22T00:00:00Z